论文部分内容阅读
鉴于我国糖尿病人的治疗绝大部分处于治疗不当和治不达标状态 ,而DCCT和UKPDS具有里程碑意义的研究结果肯定了长期持久恒定的治疗达标 ,可有效减少微血管并发症的发生、发展 ,也为控制大血管并发症带来了减少的趋势UKPDS显示降低血糖使致死性心肌梗塞和猝死的发生率减少 16 % ,P =0 0 5 2。为此 ,本刊综合了世界各地区具有指导性的“糖尿病控制指标”供临床参考使用。总之 ,治疗达标 ,不单是指血糖达标 ,而是要求全面达标 ,即包括血糖达标、血脂达标、血压达标、体重指数 (BMI)达标以及健康生活方式等在内的达标。血糖达标不单是空腹血糖 ,更要求三餐后餐后血糖达标 ,并一定要落实到HbA1c长期持续达标的可靠指标上做保证。否则 ,不能称之为治疗达标。医师和病人必须牢记达标目标。治疗达标近似健康人 (条件健康人 ) ,治疗达标 ,享受健康人生活质量 ;治不达标 ,并发症 (尤其是血管并发症 )必然发生、发展 ,治不达标 ,必将威胁健康、损命折寿
In view of the vast majority of diabetes treatment in our country in the treatment of improper treatment and non-compliance state, and DCCT and UKPDS landmark findings affirmed the long-term constant treatment compliance, can effectively reduce the occurrence of microvascular complications, and also Controlled macrovascular complications lead to a decreasing trend UKPDS shows a 16% reduction in the incidence of fatal MI and sudden death with lower blood glucose, P = 0 052. To this end, the magazine combines guidance in all regions of the world “Diabetes Control Index” for clinical reference. In short, the treatment of compliance, not only refers to the blood glucose compliance, but requires full compliance, that is, including blood glucose compliance, blood fat compliance, blood pressure compliance, body mass index (BMI) compliance and healthy lifestyle, including compliance. Blood glucose compliance is not only fasting blood glucose, but also requires three meals a day postprandial blood glucose compliance, and must be implemented to HbA1c long-term sustained compliance on a reliable indicator to ensure. Otherwise, can not be called the treatment standard. Physicians and patients must keep their goals in mind. Treatment of similar standards of healthy people (healthy people), treatment standards, to enjoy the quality of life of healthy people; treatment is not up to standard, complications (especially vascular complications) will inevitable, development, treatment fails to meet the standard, will threaten health, loss of life